Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature

Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature

In patients undergoing solid organ transplantation, the presence of an interleukin-1 (IL-1) driven disease may require the addition of IL-1 inhibiting drugs to the standard immunosuppressive regimen to protect against inflammation and negative graft outcome. Three patients undergoing renal transplan...

Full description

Bibliographic Details
Main Authors: Catharina M. Mulders-Manders, Marije C. Baas, Femke M. Molenaar, Anna Simon
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-05-01
Series:Frontiers in Pharmacology
Subjects:
anakinra
interleukin 1
organ transplantation
renal transplantation
immunosuppressive drugs
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00342/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00342/full

Similar Items